.
In a world first, Melbourne scientists have discovered a new type of anti-cancer drug that can put cancer cells into a permanent sleep, without the harmful side-effects caused by conventional cancer t...
Cancer Therapeutics CRC (CTx), a small molecule oncology drug discovery and development group partnered with some of Australia’s pre-eminent medical research institutions, is pleased to announce two...
Mr Brett Carter will succeed Dr Warwick Tong who has led CTx for the past 6 years and who will continue to provide services to the organisation in an advisory capacity. These changes reflect a transit...
Congratulations to CTx Participants CSIRO and Clinical Genomics - members of the Colvera team that won the 2017 Johnson & Johnson Eureka prize for Innovation in Medical Research. Colvera is a...
Cancer Therapeutics CRC (CTx) is proud to announce that it received the Australian CRC Association’s (CRCA) Award for Excellence in Innovation at the annual awards dinner in Canberra on 24 May. The...
The Victorian Comprehensive Cancer Council has announced a new Executive Director to lead the organisation from 3 April 2017. After an international search, Australian clinician-scientist, Professor G...